novo nordisk semaglutide shortage In Europe, shortages of Nordisk's Ozempic to persist into Q4: letter Novo Nordisk, FDA Score Win

There is little or no peer-reviewed evidence that CJC1295 gives any advantage in sports, and as a growth hormone-releasing substance, is banned by WADA

10.3906/biy-2003-8 84 Pferschy-WenzigE.-M.PausanM

Do not use GLP-1s if you: Have a personal or family history of certain types of thyroid cancer (e.g., medullary thyroid carcinoma) or multiple endocrine neoplasia type 2 Have had pancreatitis or gallbladder disease unless cleared by your doctor Are pregnant, planning to become pregnant, or breastfeeding Have severe gastrointestinal disease (consult your healthcare provider) Common side effects may include: Nausea, especially during the first few weeks Constipation or diarrhea Fatigue or low energy Mild stomach cramping Temporary decrease in appetite To reduce side effects, your provider will typically start with a low dose and increase gradually

Meet our experts Dr

This proactive approach can prevent severe pain and improve patient quality of life

Thanks for sharing